9-137877990-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000718.4(CACNA1B):c.57G>A(p.Glu19=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,151,934 control chromosomes in the GnomAD database, including 2,573 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 621 hom., cov: 34)
Exomes 𝑓: 0.15 ( 1952 hom. )
Consequence
CACNA1B
NM_000718.4 synonymous
NM_000718.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 2.04
Genes affected
CACNA1B (HGNC:1389): (calcium voltage-gated channel subunit alpha1 B) The protein encoded by this gene is the pore-forming subunit of an N-type voltage-dependent calcium channel, which controls neurotransmitter release from neurons. The encoded protein forms a complex with alpha-2, beta, and delta subunits to form the high-voltage activated channel. This channel is sensitive to omega-conotoxin-GVIA and omega-agatoxin-IIIA but insensitive to dihydropyridines. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 9-137877990-G-A is Benign according to our data. Variant chr9-137877990-G-A is described in ClinVar as [Benign]. Clinvar id is 1237524.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1B | NM_000718.4 | c.57G>A | p.Glu19= | synonymous_variant | 1/47 | ENST00000371372.6 | NP_000709.1 | |
LOC100133077 | NR_121583.1 | n.2692-2310C>T | intron_variant, non_coding_transcript_variant | |||||
CACNA1B | NM_001243812.2 | c.57G>A | p.Glu19= | synonymous_variant | 1/47 | NP_001230741.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1B | ENST00000371372.6 | c.57G>A | p.Glu19= | synonymous_variant | 1/47 | 5 | NM_000718.4 | ENSP00000360423 | P4 | |
ENST00000371390.1 | n.2692-2310C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17562AN: 148902Hom.: 623 Cov.: 34
GnomAD3 genomes
AF:
AC:
17562
AN:
148902
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.117 AC: 1322AN: 11300Hom.: 0 AF XY: 0.115 AC XY: 644AN XY: 5594
GnomAD3 exomes
AF:
AC:
1322
AN:
11300
Hom.:
AF XY:
AC XY:
644
AN XY:
5594
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.153 AC: 153455AN: 1002922Hom.: 1952 Cov.: 30 AF XY: 0.154 AC XY: 73141AN XY: 474756
GnomAD4 exome
AF:
AC:
153455
AN:
1002922
Hom.:
Cov.:
30
AF XY:
AC XY:
73141
AN XY:
474756
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.118 AC: 17551AN: 149012Hom.: 621 Cov.: 34 AF XY: 0.119 AC XY: 8622AN XY: 72698
GnomAD4 genome
AF:
AC:
17551
AN:
149012
Hom.:
Cov.:
34
AF XY:
AC XY:
8622
AN XY:
72698
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 28, 2020 | - - |
CACNA1B-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 01, 2023 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at